Suk-Hyung Kwon

Vorstandsvorsitzender bei NOVAREX CO.,LTD.

Vermögen: 25 Mio $ am 30.04.2024

69 Jahre

Health Technology

Finance

Consumer Services

Aktive Positionen von Suk-Hyung Kwon

Unternehmen	Position	Beginn	Ende
NOVAREX CO.,LTD.	Vorstandsvorsitzender	22.03.2019	-
	Vorsitzender	22.03.2019	-
	Präsident	-	-
NOVAKMED	Vorstandsvorsitzender	02.01.2017	-
Korea Health Supplements Association	Vorsitzender	25.02.2016	-
STIC Investments, Inc. (South Korea) STIC Investments, Inc. (South Korea) Investment ManagersFinance STIC Investments, Inc. (South Korea) is a private equity subsidiary of STIC Investments, Inc. founded in 1999 by Yong-Hwan Do and Byung-Won Choi. STIC Investments, Inc. (South Korea) is headquartered in Seoul, South Korea.	Private-Equity-Analyst	-	-

Unternehmen	Position	Beginn	Ende
REXAHN PHARMACEUTICALS, INC.	Direktor/Vorstandsmitglied	01.03.2001	14.06.2005

Chung-Ang University

Doctorate Degree

International

Operativ

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
NOVAREX CO.,LTD.	Health Technology

Private Unternehmen	4
Rexahn Pharmaceuticals, Inc. Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, MD.	Health Technology
STIC Investments, Inc. (South Korea) STIC Investments, Inc. (South Korea) Investment ManagersFinance STIC Investments, Inc. (South Korea) is a private equity subsidiary of STIC Investments, Inc. founded in 1999 by Yong-Hwan Do and Byung-Won Choi. STIC Investments, Inc. (South Korea) is headquartered in Seoul, South Korea.	Finance
Korea Health Supplements Association
NOVAKMED